CS
Chinnadharavaram Sundaresan Muralidharan
About Chinnadharavaram Sundaresan Muralidharan
Data last updated:
Chinnadharavaram Sundaresan Muralidharan is an Additional Director at Maiva Pharma Private Limited (since 2026), Director at Emcure Pharmaceuticals Limited (since 2026) and Whole-Time Director at Kryvos Advisors Private Limited (since 2025). The companies operate in Pharma, Outsourcing and Chemicals. The largest current company by reported revenue is Maiva Pharma Private Limited at ₹399 Cr (FY 2025). Earlier, Chinnadharavaram Sundaresan Muralidharan was a Cfo at Sun Pharma Laboratories Limited (2017–2025) and Cfo at Sun Pharmaceutical Industries Limited (2017–2025) and 11 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 13 Jan 2026 | 1993 | ₹399 Cr (FY 2025) | Active | |
| Director | 01 Apr 2026 | 1981 | Active | ||
| Whole-Time Director | 22 Oct 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Cfo | 19 Jun 2017 | 1997 | ₹12,715 Cr (FY 2024) | Active | |
| Cfo | 19 Jun 2017 | 1993 | ₹60,434 Cr (FY 2026) | Active | |
| Director | 10 Feb 2006 | 1984 | ₹888 Cr (FY 2023) | Active | |
| Director | 28 Sep 2016 | 2002 | ₹1,456 Cr (FY 2025) | Active | |
| Director | 14 Jan 2013 | 2006 | ₹36.32 Cr (FY 2016) | Amalgamated | |
| Director | 30 Sep 2016 | 2003 | ₹294 Cr (FY 2025) | Active | |
| Managing Director | 20 May 2010 | 2005 | ₹1,020 Cr (FY 2025) | Active | |
| Director | 14 Jan 2013 | 2006 | ₹70.34 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Chinnadharavaram Sundaresan Muralidharan
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chinnadharavaram Sundaresan Muralidharan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chinnadharavaram Sundaresan Muralidharan
Chinnadharavaram Sundaresan Muralidharan currently holds 3 directorships: Maiva Pharma Private Limited (Additional Director, since 13 Jan 2026, revenue ₹399 Cr (FY 2025)); Emcure Pharmaceuticals Limited (Director, since 01 Apr 2026); Kryvos Advisors Private Limited (Whole-Time Director, since 22 Oct 2025).
Chinnadharavaram Sundaresan Muralidharan was first appointed on 10 Feb 2006 as Director at Concord Biotech Limited. The most recent appointment on record is 01 Apr 2026 at Emcure Pharmaceuticals Limited.
Chinnadharavaram Sundaresan Muralidharan held 13 earlier board appointments: Sun Pharma Laboratories Limited (Cfo, 19 Jun 2017 to 01 Jul 2025); Sun Pharmaceutical Industries Limited (Cfo, 19 Jun 2017 to 01 Jul 2025); Concord Biotech Limited (Director, 10 Feb 2006 to 29 Sep 2007); Teva Api India Private Limited (Director, 28 Sep 2016 to 15 Jun 2017); Vivimed Labs (Alathur) Private Limited (Director, 14 Jan 2013 to 31 Jul 2013); and 8 more.
The current boards of Chinnadharavaram Sundaresan Muralidharan's companies include Arumugam Bhaskar Krishna (Maiva Pharma Private Limited), Buggana Hariharnath (Maiva Pharma Private Limited), Janardhan (Maiva Pharma Private Limited), Nirav Vinod Mehta (Maiva Pharma Private Limited), Shivananda Kuppayya Hegde (Maiva Pharma Private Limited), Vaibhav Bagri (Maiva Pharma Private Limited), among others.